— peptide / growth —
Synthetic 29-amino-acid N-terminal fragment of native GHRH investigated as the minimal bioactive sequence for growth hormone-releasing activity.
Guillemin (Nobel 1977) foundational GHRH. Frohman 1980s-90s. Geref clinical reports. Read more →
From Retail $46 USDT
Member $40.00 USDT
Members save 15% — free to join
Order now to reserve — we'll ship as soon as inventory is replenished.
Research-grade material. Documentation summarizes published literature in third-person scientific context. Not medical advice; not for human consumption.
— Pricing —
All prices in USDT. Crypto pays settle directly to our wallet.
Single vial
Retail $46 USDT
Member $40.00 USDT
Members save 15% — free to join
1 vial · $40.00 USDT per vial
Most flexible
Pre-order reserves your spot in the restock queue.
USDT settlement · 3% off if you pay in crypto.
5-Pack
Save 14%Retail $198 USDT
Member $172.00 USDT
Members save 15% — free to join
5 vials · $34.40 USDT per vial
Researcher's choice
Pre-order reserves your spot in the restock queue.
USDT settlement · 3% off if you pay in crypto.
10-Pack
Best valueRetail $288 USDT
Member $250.00 USDT
Members save 15% — free to join
10 vials · $25.00 USDT per vial
Pre-order reserves your spot in the restock queue.
USDT settlement · 3% off if you pay in crypto.
— The literature —
Sermorelin binds the GHRH receptor, a class B G-protein coupled receptor expressed on pituitary somatotrophs and at lower levels in extra-pituitary tissues including the hypothalamus and pancreas. Receptor engagement activates Gas, elevates intracellular cAMP, and stimulates protein kinase A-dependent transcription of the growth hormone gene as well as exocytosis of stored hormone from somatotroph secretory granules.
The native GHRH sequence is cleaved at the position 2 Ala-Asp bond by dipeptidyl peptidase-4, yielding the inactive GHRH (3-29) metabolite within minutes of administration. This rapid clearance limits sermorelin to short receptor-exposure durations, producing single growth hormone pulses with each administration. The pulse pattern recapitulates the dynamics of endogenous GHRH release more faithfully than long-acting analogs, an advantage in research contexts where pulsatile rather than sustained somatotroph activation is desired.
All compounds discussed are intended for research use only. Not for human consumption. Research-context information is educational and does not constitute medical advice.
View the full disclaimer →— Available strengths —